145P Impact of immunotherapy addition to dose density of neoadjuvant chemotherapy for triple-negative breast cancer: A retrospective, real-world study from multiple centres in Lond... von Veli, M., Fessas, P., Millar, L.A., Koske, D., Dasgupta, R., Creed, C., Raja, F., Sheri, A., Konstantis, A.A., Remilah, A. Abu, Papadimitraki, E.

Volltext

The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review von Remilah, Areen Abu, Krayim, Bilal, Amir, Eitan, Tibau, Ariadna, Robson, Mark E., Abuhadra, Nour, Chen, Yuan, Shepshelovich, Daniel, Goldvaser, Hadar

Volltext

A phase 1b study of chemoimmunotherapy with pegylated liposomal doxorubicin and pembrolizumab in estrogen receptor-positive, endocrine-resistant breast cancer von Gabizon, Alberto A., Cherny, Nathan, Isacson, Rut, Abu Remilah, Areen, Gabizon, Alberto, Shmeeda, Hilary, Rosengarten, Ora

Volltext

The Impact of Previous Therapy on Overall-Survival in Registration Clinical Trials for 1 st Line Metastatic Breast Cancer von Remilah, Areen Abu, Krayim, Bilal, Amir, Eitan, Tibau, Ariadna, Robson, Mark E, Abuhadra, Nour, Chen, Yuan, Shepshelovich, Daniel, Goldvaser, Hadar

Volltext